Mundipharma
Richard Fazackerley is an accomplished leader in the pharmaceutical industry with extensive experience in technical project management and supply chain operations. Currently serving as the Director of Technical Project Management at Mundipharma, Fazackerley previously held positions such as Global Head of Supply Chain Management at Signant Health and Head of Supply Chain at Clinigen Group, where responsibilities included overseeing group warehouses and technical functions. With a background that spans roles in technical strategy, product realization, and quality assurance, Fazackerley has successfully managed substantial pharmaceutical capital projects and complex supply chains, contributing to significant efficiencies and product launches in international markets. Richard Fazackerley holds degrees in Chemistry from North Staffordshire Polytechnic and the University of Staffordshire.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.